What is LOPJLB’s current signal on VYGR?

LOPJLB’s latest quantitative signal on Voyager Therapeutics, Inc. (VYGR) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is VYGR in?

Voyager Therapeutics, Inc. (VYGR) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Voyager Therapeutics, Inc. (VYGR) do?

Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophi…